J&J pauses COVID-19 vaccine trials due to illness
J&J pauses COVID-19 vaccine trials due to illness

Johnson & Johnson said on Monday it had temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness in a study participant, delaying one of the highest profile efforts to contain the global pandemic.

Gloria Tso reports.